. This research indicates the likely usage of tucidinostat within the therapy of MM Sooner or later (Huang et al., 2019). Sunshine et al. disclosed that tucidinostat is efficient in MM cure through regulating amounts of H3K27ac to enhance the transcription of succinate dehydrogenase subunit A ( Activation in the https://brefeldin-a66543.digiblogbox.com/55190916/lgk974-no-further-a-mystery